Search for: "IN THE INTEREST OF: D. R." Results 3521 - 3540 of 26,913
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jan 2020, 1:15 pm by Gene Quinn
Despite the best efforts of Senator Thom Tillis (R-NC) and Senator Chris Coons (D-DE), efforts to reform America’s patent system for the better have stalled to the point that the Senate IP Subcommittee is moving on from patent matters and will focus on copyright reform throughout 2020. [read post]
29 Jan 2020, 12:12 pm by Kevin LaCroix
The updated report also includes several new interesting perspectives on the past year’s securities litigation filings, particularly with respect to state court lawsuit filings. [read post]
29 Jan 2020, 2:47 am by Matthias Weller
by José Antonio Briceño Laborí, Professor of Private International Law, Universidad Central de Venezuela y Universidad Católica Andrés Bello In 2019 the Venezuelan Private International Law (hereinafter “PIL”) academic community made clear that, despite all the difficulties, it remains active and has the energy to expand its activities and undertake new challenges. [read post]
29 Jan 2020, 1:14 am by Asma Alouane
Civ. 1ère, 18 déc. 2019, n°18-11815 and 18-12327), the Cour de cassation decided that the intended non-biological father must have its legal relationship with the child recognized too. [read post]
27 Jan 2020, 11:45 am by Kevin LaCroix
Many of his paintings are unusual and interesting. [read post]
27 Jan 2020, 9:36 am by Dan Harris
You also get the fresh air and because I walk so much as it is, I feel like I’d be getting paid for doing what I already do, while getting the chance to do a lot more of it. [read post]
27 Jan 2020, 8:43 am by Eugene Volokh
The Journal obviously held much more than a "regulatory" interest in its forthcoming columns. [read post]
27 Jan 2020, 4:34 am
Yes, there are commercial interests here, but there are overriding national interests... unless there are not.So which is it? [read post]
27 Jan 2020, 12:33 am by Kevin LaCroix
We also visited the Kreuzburg neighborhood the next afternoon, which was also a very interesting place to visit. [read post]
26 Jan 2020, 7:57 am by J
Finally, I’m very interested in this tension between the art.8 rights of the Gyspy and Traveller community and the wider law of trespass. [read post]
26 Jan 2020, 7:57 am by J
Finally, I’m very interested in this tension between the art.8 rights of the Gyspy and Traveller community and the wider law of trespass. [read post]
26 Jan 2020, 4:00 am by Administrator
Every week we present the summary of a decision handed down by a Québec court provided to us by SOQUIJ and considered to be of interest to our readers throughout Canada. [read post]
25 Jan 2020, 7:18 am by Bill Marler
” “Amazon didn’t provide the information about the seriousness of the recall and the reason,” contended Sarah Sorscher, deputy director of regulatory affairs for the Center for Science in the Public Interest. [read post]
24 Jan 2020, 12:30 pm by John Ross
This event will be held in Arlington, Virginia on March 28, and we'd love to see you there! [read post]
24 Jan 2020, 9:58 am by Reid F. Herlihy
The Final Regulations further define the activity of “servicing mortgage loans” as follows: “[R]eceiving any scheduled periodic payments from a borrower pursuant to the terms of any mortgage loan, including amounts for escrow accounts under Section 6-k of the Banking Law, Title 3-A of Article IX of the Real Property Tax Law or of RESPA of 1974 as amended (12 USC 2609), and making payments to the owner of the loan or other third parties of principal and interest… [read post]
24 Jan 2020, 4:57 am by MBettman
R. 201(D) provides that courts must take judicial notice upon a party’s request and if supplied with the necessary information. [read post]
23 Jan 2020, 12:55 pm by Alexa von Uexküll
To the disappointment of research-based pharmaceutical industry, the principal suggestion of the Advocate General is that the CJEU should completely abandon the Neurim approach and return to a strict literal interpretation of the Article 3(d) requirement, such that SPCs would no longer be available for any new therapeutic applications of previously approved active ingredients. [read post]